Kopran Ltd
NSE: KOPRAN · Pharmaceuticals · sector
₹249.20NSE close 2026-10-26
Key numbers
Market cap₹1,203 cr
Price₹249.20
52w high / low₹296 / ₹107
P/E48.2xSector median 27.9x
P/B2.3xSector median 2.9x
Book value₹109.8
Dividend yield1.21%Sector median 0.48%
ROE4.8%Sector median 11.7%
ROCE6.5%Sector median 12.3%
OPM8.8%Sector median 14.0%
Debt / equity0.29xSector median 0.16x
EV/EBITDA22.0xSector median 18.6x
Interest cover4.0x
Current ratio1.51x
Sales growth 3y+7.3%Sector median +9.6%
Profit growth 3y-1.9%Sector median +13.3%
PEG–
Last 12 months to Jun 2026, Consolidated. "Sector median" = middle value of 185 companies in Pharmaceuticals (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Cash ₹7 cr vs borrowings ₹153 cr (FY26): borrowings are higher by ₹145 cr.
- Borrowings rose in each of the last 3 years (₹75 cr → ₹153 cr).
- Operating profit covered interest 4.0x in the last 12 months.
- No promoter shares are pledged.
- Promoter holding fell by 2.60 percentage points in a year, to 41.82% (2026-09-30).
- Operating cash flow was below net profit in 1 of the last 5 years (FY22).
- Net loss in 1 of the last 8 quarters.
- Revenue was higher than a year earlier in 3 of the last 4 quarters.
- Other income was 9% of net profit in the last 12 months.
- Debtor days went from 126 (FY24) to 141 (FY26).
- Dividend paid in 5 of the last 5 financial years.
- Price ₹249.20 on 2026-10-26: -15.8% from the 52-week high, +132.9% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Weekly close · high ₹342.85 · low ₹113.47
RevenueNet profit
RevenueNet profit
Quarterly results
| ₹ cr | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 152 | 166 | 172 | 135 | 118 | 194 | 234 | 154 |
| EBITDA | 15 | 20 | 17 | 14 | -5 | 18 | 33 | 16 |
| OPM % | 9.7% | 11.9% | 9.9% | 10.4% | -4.5% | 9.1% | 14.1% | 10.3% |
| Other income | 1 | 0 | 3 | 3 | 0 | 0 | 0 | 2 |
| Net profit | 7 | 10 | 10 | 7 | -10 | 9 | 19 | 7 |
| EPS (₹) | 1.53 | 0.00 | 2.01 | 1.54 | -2.06 | 1.93 | 3.91 | 1.39 |
| Revenue YoY | -22.2% | +16.9% | +35.8% | +13.9% | ||||
| Profit YoY | -234.4% | -10.2% | +94.9% | -10.1% |
Consolidated figures where filed. Latest quarter Jun 2026.
Profit & loss (yearly)
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|---|---|
| Revenue | 478 | 551 | 615 | 630 | 681 | 700 |
| EBITDA | 87 | 52 | 74 | 73 | 62 | 61 |
| Net profit | 61 | 27 | 0 | 39 | 26 | 25 |
| EPS (₹) | 13.77 | 5.65 | 10.57 | 7.99 | 5.33 | 5.17 |
| Revenue growth | +15.4% | +11.5% | +2.4% | +8.2% | +12.0% | |
| Profit growth | -55.4% | -99.2% | +18,257.1% | -33.3% | -28.4% | |
| Dividend / share (₹) | 1.50 | 3.00 | 3.00 | 3.00 | 3.00 |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | +7.3% | +6.7% | +12.0% |
| Net profit | -1.9% | -16.0% | -28.4% |
| EPS | -1.9% | -17.8% | – |
| Share price | – | -6.5% (2y) | +55.8% |
Balance sheet
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Shareholders' equity | – | 439 | 491 | 518 | 530 |
| Borrowings | – | 75 | 99 | 148 | 153 |
| Cash & equivalents | – | 13 | 14 | 26 | 7 |
| Total assets | – | 650 | 743 | 844 | 908 |
| Fixed assets | – | 163 | 179 | 197 | 337 |
| Capital work in progress | – | 56 | 78 | 99 | 2 |
| Investments | – | 0 | 0 | 0 | 0 |
| Receivables | – | 163 | 212 | 215 | 263 |
| Inventory | – | 131 | 138 | 169 | 164 |
| Payables | – | 87 | 113 | 119 | 158 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash from operations | -34 | 34 | 43 | 42 | 67 |
| Cash from investing | -84 | -13 | -44 | -56 | -65 |
| Cash from financing | 123 | -20 | 1 | 26 | -21 |
| Capex | 42 | 61 | 57 | 59 | 67 |
| Free cash flow | -76 | -27 | -13 | -17 | -0 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| ROE % | – | 6.2% | 0.0% | 7.4% | 4.9% |
| ROCE % | – | 8.2% | 12.9% | 9.2% | 6.6% |
| Debtor days | – | 108 | 126 | 125 | 141 |
| Inventory days | – | 133 | 126 | 153 | 137 |
| Payable days | – | 89 | 103 | 108 | 131 |
| Cash conversion cycle (days) | – | 152 | 149 | 170 | 147 |
| Working capital days | – | 147 | 140 | 149 | 95 |
Shareholding
| Holder | % (2026-09-30) |
|---|---|
| Promoters | 41.82% |
| FIIs | 0.91% |
| DIIs | 0.00% |
| of which Mutual funds | 0.00% |
| Public (non-institutions) | 57.27% |
| Quarter | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters % | 44.46% | 44.42% | 44.42% | 44.42% | 44.42% | 44.42% | 44.42% | 41.82% |
| Promoter group | % |
|---|---|
| Oricon Enterprises Limited | 12.87% |
| Panorama Finvest PVT Ltd | 7.86% |
| Sarvamangal Mercantile Co Ltd | 6.36% |
| Oriental Enterprises (Surendra Somani) | 3.65% |
| Varun Surendra Somani | 3.57% |
| Vandana Somani | 2.00% |
| Surendra Somani | 1.99% |
| Parijat Shipping and Finale Ltd. | 1.89% |
| United Shippers Ltd | 1.64% |
| Susheel Somani | 0.00% |
| Hridai Susheel Somani | 0.00% |
| Mridula Somani | 0.00% |
| Jaya Somani | 0.00% |
| MR Adarsh Somani | 0.00% |
| Suhrid Somani | 0.00% |
| Public holders above 1% | % |
|---|---|
| Madhuri Madhusudan Kela | 1.72% |
| Zaki Abbas Nasser | 1.62% |
| Laxminarayan Vyapaar P Ltd | 1.55% |
| Nisarg Ajaykumar Vakharia | 1.50% |
| Krishnamurthy C G | 1.17% |
52,924 shareholders. Pledged: 0.00% of promoter shares.
Peers in Pharmaceuticals
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| SUNPHARMA | ₹4,17,478 cr | 34.5x | 5.0x | 15.5% | 18.7% | 28.6% | +10.0% | 0.94% |
| DIVISLAB | ₹2,39,825 cr | 82.1x | 14.3x | 18.4% | 23.0% | 34.7% | +10.8% | 0.34% |
| TORNTPHARM | ₹1,53,999 cr | 72.7x | 18.4x | 27.3% | 15.1% | 32.3% | +13.3% | 0.84% |
| ZYDUSLIFE | ₹1,15,808 cr | 25.9x | 4.3x | 17.7% | 16.8% | 27.2% | +16.4% | 0.95% |
| LAURUSLABS | ₹1,11,232 cr | 101.6x | 21.0x | 22.4% | 20.8% | 28.0% | +4.1% | 0.08% |
| CIPLA | ₹1,09,464 cr | 32.5x | 3.2x | 10.3% | 13.2% | 17.7% | +7.4% | 1.18% |
| DRREDDY | ₹1,09,460 cr | 33.9x | 2.9x | 9.0% | 10.1% | 15.5% | +11.0% | 0.61% |
| MANKIND | ₹95,486 cr | 46.7x | 5.9x | 13.4% | 13.8% | 25.1% | +17.7% | 0.04% |
| AUROPHARMA | ₹91,489 cr | 24.9x | 2.4x | 10.5% | 12.8% | 20.0% | +10.6% | 0.26% |
| KOPRAN | ₹1,203 cr | 48.2x | 2.3x | 4.8% | 6.5% | 8.8% | +7.3% | 1.21% |
Dividends & corporate actions
| Ex-date | Action | Detail |
|---|---|---|
| 2026-08-11 | Dividend | Dividend - Rs 3 Per Share |
| 2025-09-04 | Dividend | Dividend - Rs 3 Per Share |
| 2024-09-02 | Dividend | Annual General Meeting/Dividend - Rs 3 Per Share |
| 2023-09-07 | Dividend | Annual General Meeting/Dividend - Rs 3 Per Share |
| 2022-08-04 | Dividend | Dividend - Rs 3 Per Share |
| 2021-08-05 | Dividend | Dividend - Rs 1.50 Per Share |
| 2020-11-05 | Dividend | Interim Dividend - Rs 1.50 Per Share |
| 2020-09-03 | Other | Annual General Meeting |
| 2019-07-08 | Other | Annual General Meeting |
| 2018-08-27 | Other | Annual General Meeting |
| 2017-08-29 | Other | Annual General Meeting |
| 2016-09-06 | Other | Annual General Meeting |
| 2015-09-15 | Other | Annual General Meeting |
| 2014-09-04 | Other | Annual General Meeting |
| 2013-09-06 | Other | Annual General Meeting |
| 2012-09-10 | Other | Annual General Meeting |
| 2011-09-19 | Other | Annual General Meeting |
| 2010-09-20 | Other | Annual General Meeting |
| 2009-09-18 | Other | Annual General Meeting |
| 2008-09-22 | Other | Annual General Meeting |
Documents
- Annual report FY26
- Annual report FY25
- Annual report FY25
- Annual report FY24
- Annual report FY23
- Announcements NSE filings
- Latest results (data file) XBRL
- Announcements BSE filings
Links go to the original files on the exchange website.
About the company
| Sector | Healthcare |
| Industry | Pharmaceuticals |
| Sub-industry | Pharmaceuticals |
| Symbol | KOPRAN |
| BSE code | 524280 |
| ISIN | INE082A01010 |
| Face value | ₹10.0 |
| Incorporated | – |
| Website | – |
| Plants (India / abroad) | – |
Data built 2026-10-22 from NSE company filings (XBRL: Integrated Filing - Financials + financial results), NSE shareholding & pledge data; price = NSE close 2026-10-26.